Tisch MS News

During the interview, Dr. Sadiq discusses the preliminary analysis of results from our FDA-approved stem cell treatment study and the exciting implications they could have for MS treatment moving forward. He also gives listeners further background on our center and some of the other groundbreaking...

June 29, 2022

More

Yesterday, our Tisch MSRCNY researchers hosted their bi-annual lab retreat. This retreat facilitates collaboration between all of our research teams with the goal of inspiring ideas for future research projects. The retreat also allows our research assistants to learn more about each team’s...

September 16, 2022

More

Last week our researchers and physicians discussed a paper about Neuromyelitis Optica Spectrum Disorder (NMOSD), an inflammatory demyelinating disease of the CNS. Specifically, NMOSD affects the optic nerves and spinal cord, and can lead to a loss of vision, and in some cases, paralysis. Though MS...

September 14, 2022

More

Our recent research paper on the potential causes of sporadic ALS (sALS) was featured in an article in BioSpace. The piece quotes Tisch MSRCNY Director and Chief Research Scientist Dr. Saud A. Sadiq, and Tisch research scientist Dr. Jamie Wong, the lead author of the research paper. The article...

September 9, 2022

More

Tisch MSRCNY research scientist Dr. Roberto Alfonso, and his recent research paper around COVID-19 vaccines, were featured in an article in Managed Healthcare Executive. In the piece, Dr. Alfonso highlights the significance of the research findings, which suggest that MS patients receiving anti-...

September 7, 2022

More

The Tisch MSRCNY – and our recent research around the potential causes of sporadic ALS (sALS), using our novel animal model – have been featured in an article in ALS News Today. Based on our research, which was recently published in Brain Communications , this piece in ALS News Today highlights the...

August 31, 2022

More

Tisch MSRCNY research scientist Dr. Roberto Alfonso has been featured on an episode of Real Talk MS podcast about our recent research paper around COVID-19 vaccines, on which he was the lead author and which was published in the journal Frontiers in Immunology . This study’s findings – which showed...

August 31, 2022

More

The Larry G. Gluck Division of ALS Research located at the Tisch MS Research Center of New York has published research in Brain Communications . In this study, Tisch researchers developed a first-of-its-kind cerebrospinal fluid-mediated mouse model to identify apolipoprotein B-100 (ApoB) as a key...

August 22, 2022

More

The paper shows that MS patients receiving anti-CD20 therapy saw strong T-cell activation in response to receiving the COVID-19 vaccination, even in conditions of deficient antibody production. Furthermore, our research found no difference in patients’ T-cell response regardless of form of the...

August 8, 2022

More

Join us in congratulating Rose for her outstanding performance as the Best Junior Scientist!

August 3, 2022

More

Pages

News Archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.